Vita PeptidesPeptideSKU VITA-RT3-10

Vita Reta RT-3 10mg

Reta (GIP, GLP-1 and glucagon triple agonist) · Lyophilized powder (vial)

$60CAD

In stock, ships from Vancouver

Strength10 mg per vial

Pack1 vial

Total per order10 mg

Half-life≈ 6 days

Add $240 more for free Xpresspost.

You will need to mix and measure it

Bacteriostatic water$60Add

EasyTouch Insulin Syringes 30G U-100 (bag of 10)$15Add

Also in a kit · 10% offLean Peptide Pair5 items · $275.40See kit Recomp Reserve11 items · $1,020.60See kit

Delivery guaranteeLost or seized: reshipped free
Tracking in 72 hPacked in Vancouver
Interace-TransferFrom any Canadian bank
Plain packagingNo product names outside

Overview

Reta is the store’s name for a triple agonist that acts on GIP, GLP-1 and glucagon receptors. It is in clinical trials for weight management and is not approved anywhere.

How it works

Adding glucagon-receptor activity to the GIP and GLP-1 effects is thought to raise energy use as well as lower appetite. Its half-life is about six days.

Clinical reference

Phase 2 trials started at 2 mg once a week and stepped up every four weeks to target amounts of 4 to 12 mg a week. It has no approval for any use.

Label and guideline amounts are shown for reference only. They are not a recommendation, and we never give cycle or performance amounts. Any use belongs under a doctor’s care, with bloodwork.

Measuring calculator

Converts an amount you enter into what to measure. It does not suggest an amount.

Bacteriostatic water addedmlYour amountEnter an amount to see the conversion.

Strength used: 10 mg per vial

Injection sites

Reta RT-3 10mg is a freeze-dried powder. After mixing with bacteriostatic water, compounds like this are usually injected subcutaneously (subQ): into the fat just under the skin with a short insulin needle.

Commonly usedAnatomy drawing: OpenStax & Tomáš Kebert, umimeto.org, CC BY-SA 4.0, recoloured.

Volume per site: About 1 ml or less
Needle: 4 to 13 mm insulin needle, 29 to 31G

**Belly injections: distance from the navel**Massachusetts General Hospital · Patient education · YouTube, plays here when clicked

Finding it. Anywhere on the belly at least 5 cm from the navel, avoiding scars and the belt line. Pinch a fold of skin and inject into it.

Why it is used. The most-used subcutaneous site: easy to see, plenty of fat and steady absorption. Weekly GLP-1 pens list it first.

Watch out. Move each injection 2 to 3 cm from the last to avoid hard lumps.

Why these sites for Reta RT-3 10mg

Subcutaneous (subQ)

Belly first. The abdomen has the most fat and the steadiest absorption, and you can see what you are doing.
Short needle, small volume. About 1 ml or less per spot with an insulin syringe. Pinch the skin if you are lean.
Move every time. Keep each injection 2 to 3 cm from the last to avoid lumps.

Every time: wash your hands, wipe the vial stopper and skin with alcohol, use a new sterile needle and syringe, and never share. See a doctor for spreading redness, heat, swelling, pus, fever or numbness. This is general guidance from standard nursing practice, not medical advice; a pharmacist or nurse can show you in person.

Combinations and interactions

Prescribed or used alongside

Bacteriostatic water and U-100 insulin syringes are needed.
Not combined with other GLP-1 class products.

Drug interactions

Insulin and diabetes medicines: low blood sugar risk.
Oral medicines: absorption may change.

Risks and bloodwork

Digestive effects

Nausea, vomiting and diarrhea were the most common in trials.

Heart rate

Trials reported a rise in resting heart rate.

Unknowns

Long-term safety has not been established.

Pancreas and gallbladder

The same watch-points as other GLP-1 class drugs.

Bloodwork doctors check

Fasting glucose and HbA1c
Kidney function (creatinine, eGFR)
Lipase if stomach pain appears
Resting heart rate
Weight and waist measurements

Not for

People under 18, anyone pregnant or breastfeeding, anyone with active cancer or a history of cancer, and anyone with diabetes unless a doctor is involved.

Canadian legal status

Health Canada has not approved this compound for human use. It is sold for research purposes, and most sports bodies prohibit it. This is general information, not legal advice.

References

A triple-hormone-receptor agonist for obesity: phase 2 trialJastreboff AM et al. · N Engl J Med, 2023 · PMID 37366315
LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of conceptCoskun T et al. · Cell Metab, 2022 · PMID 35985340

Reviews

No reviews yet.

Reviews are published after a quick check. Only customers who bought this product can review it.

Bought this before? Sign in to review it.

FAQ

Why is it called Reta?

Reta is the store’s name for this triple-agonist research peptide.

Is RT-3 the same thing?

Yes, the Vita RT-3 vial contains the same triple agonist.

Is it approved in Canada?

No, it is an investigational compound.

How fast will it arrive?

Orders ship from Vancouver by Canada Post Xpresspost. You get a tracking number within 72 hours of payment; delivery then takes 1 to 2 business days in BC, 3 to 4 in Ontario and 3 to 5 in Quebec.

What if my parcel is lost or seized?

We reship it free. Contact us with your order number.

Adults 18+. This page is general information, not medical advice. Talk to a licensed healthcare provider before using any compound.